United Therapeutics (UTHR) revenue

Revenue · fiscal 2025
$3.18B

United Therapeutics (UTHR) reported revenue of $3.18B in fiscal 2025 (the year ended December 31, 2025). That is 10.6% higher than the $2.88B of fiscal 2024. Figures as of 18 Nov 2026, 10:36 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$3.18B
Change on fiscal 2024
+10.6%
Growth, 5 years
+16.5% a year
Growth, 10 years
+8.1% a year
Highest on record
$3.18Bfiscal 2025
Lowest on record
$281.50Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

United Therapeutics revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 16.5% a year; over ten years the rate was 8.1% a year. Across the 18 fiscal years on record (2008–2025), the highest was $3.18B in fiscal 2025 and the lowest $281.50M in fiscal 2008.

History · 18 fiscal years

Revenue by fiscal year

United Therapeutics revenue, year by year

United Therapeutics (UTHR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$3.18B 10.6% up
2024$2.88B 23.6% up
2023$2.33B 20.2% up
2022$1.94B 14.9% up
2021$1.69B 13.6% up
2020$1.48B 2.4% up
2019$1.45B 11.0% down
2018$1.63B 5.7% down
2017$1.73B 7.9% up
2016$1.60B 9.1% up
2015$1.47B 13.8% up
2014$1.29B 15.4% up
2013$1.12B 21.9% up
2012$916.08M 23.3% up
2011$743.18M 25.3% up
2010$592.90M 65.2% up
2009$358.88M 27.5% up
2008$281.50M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of United Therapeutics and comparable companies
CompanyRevenueFiscal year
STERIS STE$5.94B2026
Insmed INSM$606.42M2025
United Therapeutics UTHR$3.18B2025
Incyte INCY$5.14B2025
Viatris VTRS$14.30B2025
Tenet Healthcare THC$21.31B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on UTHR

United Therapeutics, figure by figure

United Therapeutics (UTHR) overview: price, valuation and scorecardAll health care companies by market value

United Therapeutics revenue: questions and answers

What is United Therapeutics's revenue?

United Therapeutics (UTHR) reported revenue of $3.18B in fiscal 2025 (the year ended December 31, 2025). That is 10.6% higher than the $2.88B of fiscal 2024.

What is the growth rate of United Therapeutics's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 16.5% a year; over ten years the rate was 8.1% a year.

What are the highest and lowest revenue figures on record for United Therapeutics?

Across the 18 fiscal years on record (2008–2025), the highest was $3.18B in fiscal 2025 and the lowest $281.50M in fiscal 2008.

How is United Therapeutics's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For United Therapeutics it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “United Therapeutics (UTHR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/UTHR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.